simvastatin has been researched along with Acute Respiratory Distress Syndrome in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, AJ; Bradbury, I; Conlon, J; Ferris, P; McAuley, DF; O'Kane, CM; Rogers, AJ; Shankar-Hari, M | 1 |
| Blackwood, B; Clarke, M; Lee, B; McAuley, DF; McDowell, C; Verghis, RM | 1 |
| Baron, RM; Conlon, J; Guan, J; Levitt, JE; Matthay, MA; McAuley, DF; Moore, AR; O'Kane, CM; Pienkos, SM; Rogers, AJ | 1 |
| Coleman, MD; Izotov, BN; Kteniadakis, S; Papadakis, GZ; Spandidos, DA; Stancioiu, F; Tsatsakis, A | 1 |
| Chen, M; Chen, Q; Cheng, L; Geng, Y; Jiang, H; Lu, J; Wang, X | 1 |
| Agus, A; Hulme, C; Jackson, C; Laffey, JG; McAuley, DF; McDowell, C; O'Kane, CM; Verghis, RM | 1 |
| Fan, E; Lawler, PR | 1 |
| Calfee, CS; Delucchi, KL; Hackett, J; Laffey, JG; Matthay, MA; McAuley, DF; McDowell, C; O'Kane, CM; Shankar-Hari, M; Sinha, P | 1 |
| Agus, A; Campbell, C; Kennedy, G; McAuley, D; O'Kane, C; Perkins, GD; Phair, G; Shyamsundar, M | 1 |
| Gordon, A; McAuley, DF; O'Kane, C; Prevost, AT; Santhakumaran, S; Shankar-Hari, M | 1 |
| Drazen, JM; Gelijns, AC | 1 |
| Hopkins, PA; Johnston, AJ; Johnston, P; Laffey, JG; McAuley, DF; McDowell, C; McNally, C; Mullan, B; O'Kane, CM; Perkins, GD; Trinder, TJ | 1 |
| Durand, A; Gleeson, J; Grimaldi, D; Taccone, FS | 1 |
| Fessler, MB | 1 |
| An, J; Chen, YJ; Guo, LL; Shen, YC; Wang, CN; Wang, T; Wen, FQ; Xu, D; Yang, T; Zhang, XH; Zhao, L; Zuo, QN | 1 |
| Aldemir, D; Arslan, G; Candan, S; Ozen, O; Pirat, A; Yücel, M; Zeyneloglu, P | 1 |
3 review(s) available for simvastatin and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
A dissection of SARS‑CoV2 with clinical implications (Review).
Topics: Amiodarone; Animals; COVID-19; Curcumin; Humans; Pioglitazone; Respiratory Distress Syndrome; SARS-CoV-2; Simvastatin | 2020 |
[Statin in the treatment of ALI/ARDS: a systematic review and Meta-analysis based on international databases].
Topics: Acute Lung Injury; Cohort Studies; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Length of Stay; Respiration, Artificial; Respiratory Distress Syndrome; Simvastatin | 2017 |
Failure of statins in ARDS: the quest for the Holy Grail continues.
Topics: Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Randomized Controlled Trials as Topic; Renal Insufficiency; Respiration, Artificial; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Simvastatin; Treatment Failure | 2016 |
6 trial(s) available for simvastatin and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial.
Topics: Carrier Proteins; Cytokines; Humans; Inflammasomes; Interleukin-18; Respiratory Distress Syndrome; Simvastatin | 2022 |
Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials.
Topics: Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Simvastatin | 2023 |
Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial.
Topics: Adult; Aged; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality-Adjusted Life Years; Respiratory Distress Syndrome; Simvastatin; State Medicine; Time | 2017 |
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Positive-Pressure Respiration; Respiratory Distress Syndrome; Simvastatin; Time Factors | 2018 |
Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol for a randomised controlled trial.
Topics: Double-Blind Method; Elective Surgical Procedures; Esophagectomy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; One-Lung Ventilation; Pneumonectomy; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Risk Factors; Simvastatin; Time Factors; Treatment Outcome; United Kingdom | 2018 |
Simvastatin in the acute respiratory distress syndrome.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Kaplan-Meier Estimate; Male; Middle Aged; Respiration, Artificial; Respiratory Distress Syndrome; Simvastatin; Tidal Volume; Treatment Failure | 2014 |
7 other study(ies) available for simvastatin and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies.
Topics: Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Respiration, Artificial; Respiratory Distress Syndrome; Simvastatin | 2023 |
Heterogeneity and phenotypic stratification in acute respiratory distress syndrome.
Topics: Dyspnea; Humans; Intensive Care Units, Pediatric; Respiratory Distress Syndrome; Simvastatin | 2018 |
Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Topics: Adult; Aged; Anti-Inflammatory Agents; APACHE; Cardiotonic Agents; Critical Illness; Female; Guideline Adherence; Hospital Mortality; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Sepsis; Simendan; Simvastatin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2019 |
Statin strikeout.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Simvastatin; Sulfonamides | 2014 |
Simvastatin as a potential therapeutic for acute respiratory distress syndrome.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipopolysaccharides; Lovastatin; Lung; Mevalonic Acid; Mice; Neutrophils; Respiratory Distress Syndrome; Simvastatin | 2009 |
Ox-LDL-induced TGF-β1 production in human alveolar epithelial cells: involvement of the Ras/ERK/PLTP pathway.
Topics: Cell Line, Tumor; Epithelial Cells; Gene Expression Regulation; Genes, ras; Humans; Hypolipidemic Agents; Lipoproteins, LDL; MAP Kinase Kinase Kinase 3; MAP Kinase Signaling System; Mevalonic Acid; Phospholipid Transfer Proteins; Phosphorylation; Pulmonary Alveoli; Respiratory Distress Syndrome; RNA, Small Interfering; Simvastatin; Smad3 Protein; Transforming Growth Factor beta1 | 2012 |
Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats.
Topics: Animals; Intestinal Mucosa; Intestines; Lung; Lung Injury; Male; Premedication; Rats; Rats, Wistar; Reperfusion Injury; Respiratory Distress Syndrome; Simvastatin | 2006 |